Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial
Intensive Care Medicine · 2024
DOI: 10.1007/s00134-024-07448-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Intensive Care Medicine, 2024. Verfasst von Morgan T Rose und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Immunology, Centre for Antibiotic Allergy and Research, Austin Health, Level 7, Harold Stokes Building, 145 Stu…. Hauptthemen laut MEDLINE: Penicillins, Critical Illness, Feasibility Studies, Drug Hypersensitivity. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Austin Health, University of Melbourne.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Immunology, Centre for Antibiotic Allergy and Research, Austin Health, Level 7, Harold Stokes Building, 145 Studley Road, Heidelberg, VIC, 3084, Australia. Morgan.rose2@austin.org.a…
- National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Morgan.rose2@austin.org.au.
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Morgan.rose2@austin.org.au.
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia. Morgan.rose2@austin.org.au.
- Department of Infectious Diseases and Immunology, Centre for Antibiotic Allergy and Research, Austin Health, Level 7, Harold Stokes Building, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
ORCID-Profile: Morgan T Rose
Förderung
- Austin Health
- University of Melbourne
Zitieren
APA
Rose, M. T., Holmes, N. E., Eastwood, G. M., Vogrin, S., James, F., De Luca, J. F., Bellomo, R., Warrillow, S. J., Phung, M., Barnes, S. L., Murfin, B., Rogers, B., Lambros, B., Collis, B., Peel, T. N., Slavin, M. A., & Trubiano, J. A. (2024). Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial. Intensive Care Medicine. https://doi.org/10.1007/s00134-024-07448-x
Vancouver
Rose MT, Holmes NE, Eastwood GM, Vogrin S, James F, De Luca JF, et al. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial. Intensive Care Medicine. 2024. doi:10.1007/s00134-024-07448-x
BibTeX
@article{Rose2024,
author = {Rose, Morgan T and Holmes, Natasha E and Eastwood, Glenn M and Vogrin, Sara and James, Fiona and De Luca, Joseph F and Bellomo, Rinaldo and Warrillow, Stephen J and Phung, Michelle and Barnes, Sara L and Murfin, Brendan and Rogers, Ben and Lambros, Belinda and Collis, Brennan and Peel, Trisha N and Slavin, Monica A and Trubiano, Jason A},
title = {Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial},
journal = {Intensive Care Medicine},
year = {2024},
doi = {10.1007/s00134-024-07448-x}
}
EUVIMED